A Phase I Study of CX5461

NCT02719977 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

41

Enrollment

NETWORK

Sponsor class

Conditions

Cancer

Interventions

DRUG: CX5461

Sponsor

Canadian Cancer Trials Group

Collaborators

[object Object]
[object Object]